Member Info for researcher1

that would be sweet

hope you are buying OPTI products in that case? :-)

yep, lot's of chubby Russians there....

hmm, not sure about low financial significance - Cyprus looks an excellent target market - multi-nationality, with non-Greeks often putting on excessive weight etc. I would expect good revenues there.

I'm not sure we need a catalyst other than the trials nearing conclusion - unlike most trials we don't need to worry about placebo, and EVERY other trial has gone to plan - there will be upward pressure - but it's still a case of who blinks first and whether day-traders will be sniffing around for a fast buck until the results pop.

no that's too soon - we'll need the trial results first and they won't come until the recruitment is filled sometime in Q1 19. The SP will rise in anticipation though - AGL has plenty of big hitters on board or interested and they won't want to scrabble for shares with everyone else.

get more today - cheaper...

definitely am now :-)

guilty - my statement was giving me a mid price, so I wouldn't be in profit if I sold...

(p.s. I did buy a few more at 8p, though it only brought the average down 0.15)

ah, profit...

and you MBMW.
Pleased to see this purchase - it was a niggling worry in the background...

a modest prediction, IMO (but probably best to err on the side of caution)

what's to like?? I've got £5K more than I had last week :-)

question is, how high are we going? with FDA approval, 80p is pretty much guaranteed, before sales. If everyone wakes up to the simplicity and efficacy of the technology, then 80p becomes £8 (well, maybe £7 and a bit) and someone has to organise a share split to keep it liquid.

I'm out too, until it goes down to 30p again. Happy with a £4K profit...

great development - I did not expect this capability.

hallelujah

yep I did say it was a buy at 10.5 - though of course before the latest (somewhat insignificant) delay. So I now have an average of 9.4, would have jumped at that at any point in Scancell's history, yet am £3K in the red! can you believe it? A sale of the IP around five years ago would have been worth about 70p per share. But no, let's do it ourselves, slowly, inefficiently. The good news is that the current IP is still worth about 50p per share minimum, even with all the dilution, because it has been expanded and so well-proven. Maybe someone going to the AGM could keep repeating the mantra: sell sell sell....

I didn't see much lipstick! they are not in charge of recruiting, and we know it can be difficult to get this kind of matched sample group together. 3 months behind is only bad if you are in a bear market .... ah,......

on good news - amazing. It is not even Angle's responsibility! AIM shares being sold for the hell of it....